(1) Proposed removal of auditor (2) proposed appointment of auditor (3) proposed change in use of proceeds from the global offering and (4) notice of the 2026 first extraordinary general meeting
Filed with HKEX · Stock code 2565 ·
6ix is reading this filing.
View original source (HKEXnews)PegBio Co., Ltd. on 6ix
Earlier from PegBio
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- 2026 Interim Report
- Change in use of proceeds from the global offering
- Proposed change of auditor
- Voluntary announcement core product Visepegenatide injection passed the preliminary review in accordance with the 2026 national reimbursement drug list adjustment
Later from PegBio
- Notice of the 2026 first extraordinary general meeting
- Form of proxy for use at the 2026 first extraordinary general meeting to be held on Thursday, November 12, 2026
Follow PegBio into a list and get an email when it puts out news.
Follow PegBio